... North America L.P. bought a new position in CymaBay Therapeutics during the second quarter worth about $242,000. Ardsley Advisory Partners lifted its holdings in CymaBay Therapeutics by 66.2% during the second quarter. Ardsley Advisory Partners now ...
http://ift.tt/2noMdYC
No comments:
Post a Comment